Skip to NavigationSkip to content

News

In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in patients with a specific...
A new study revealed that 22.1% of patients who were treated for pneumonia required further treatment after receiving antibiotics, in a worrying...
MSD is facing legal trouble after the Competition and Marketing Authority (CMA) alleged that the pharmaceutical firm had engaged in anti-...
Scott Gottlieb, the newly appointment FDA Commissioner, has indicated that his first priority is to tackle the opioid crisis currently wracking the...
In this issue, we cover the latest developments in UK life sciences, the shocking cyber attack on the NHS, and examine the latest trends in drug...
Eisai and Bial have revealed that their drug Zebinix (eslicarbazepine acetate) has been awarded marketing authorisation by the European Commission...
Baking soda – not just a baking ingredient, it is also a life-saving medicine that all hospitals carry. However, there is currently a...
AstraZeneca has been mulling over mixed news this week after both its severe asthma treatment and diabetes therapy saw varying levels of success in...
The Conservative party has learned to its cost that you do not threaten the elderly vote, after they were forced into an embarressing climb down over...
The FDA has awarded Sanofi and Regeneron’s Kevzara (sarilumab) approval for the treatment of moderate to severely active rheumatoid arthritis (RA)...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches